isocarboxazid has been researched along with Adjustment Disorders in 3 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Adjustment Disorders: Maladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms (depression, anxiety, etc.) that are in excess of a normal and expected reaction to the stressor.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zisook, S | 1 |
Braff, DL | 1 |
Click, MA | 1 |
Van Renynghe, G | 1 |
Winston, F | 1 |
1 trial available for isocarboxazid and Adjustment Disorders
Article | Year |
---|---|
Monoamine oxidase inhibitors in the treatment of atypical depression.
Topics: Adjustment Disorders; Adolescent; Adult; Bipolar Disorder; Clinical Trials as Topic; Depressive Diso | 1985 |
2 other studies available for isocarboxazid and Adjustment Disorders
Article | Year |
---|---|
[Are the MAOIs outmoded?].
Topics: Adjustment Disorders; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Delusions; Depression; | 1972 |
Combined antidepressant therapy.
Topics: Adjustment Disorders; Adult; Amitriptyline; Depression; Electroconvulsive Therapy; Female; Humans; I | 1971 |